Response to “Early hydroxychloroquine but not chloroquine use reduces ICU admission in COVID-19 patients”

• Marijke Linschoten,
• Linda Nab,
• Iwan C.C. van der Horst,
• Robert Tieleman,
• Folkert W. Asselbergs

Affiliations

Marijke Linschoten

Department of Cardiology, Division of Heart and Lungs, University Medical Center Utrecht, Utrecht University, P.O. Box 85500, 3584 CX Utrecht, The Netherlands

Linda Nab

Department of Clinical Epidemiology, Leiden University Medical Center, Postzone C7-P, P.O. Box 9600, 2300 RC Leiden, The Netherlands

Iwan C.C. van der Horst

Department of Critical Care, University Medical Center Maastricht, P. Debyelaan 25, 6229 HX Maastricht, The Netherlands

Robert Tieleman

Department of Cardiology, Martini Hospital, Van Swietenplein 1, 9728 NT Groningen, The Netherlands

Folkert W. Asselbergs

Department of Cardiology, Division of Heart and Lungs, University Medical Center Utrecht, Utrecht University, P.O. Box 85500, 3584 CX Utrecht, The Netherlands; Institute of Cardiovascular Science, Faculty of Population Health Sciences, University College London, Roger Williams Building 69-75 Chenies Mews, London WC1E 6HX, United Kingdom; Health Data Research UK and Institute of Health Informatics, University College London, 222 Euston Road, London NW1 2DA, United Kingdom; Corresponding author at: Department of Cardiology, Division Heart & Lungs, University Medical Center Utrecht, Room E03.511, P.O. Box 85500, 3508 GA Utrecht, The Netherlands.